VERX

Vertex, Inc.
$13.56
+0.04 (+0.30%)
Mkt Cap 2.20B
Volume 1,255,235
52W Range 10.21-26.54
Sector Technology
Beta 0.81
EPS (TTM) 0.03 USD
P/E Ratio 443.14
Revenue (TTM) 787.44M USD
Rev Growth (5Y) +14.8%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$7.83
Overvalued strong signal
73.2% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018
Revenue 748.44M 666.78M 572.39M 491.62M 425.55M 374.67M 321.50M 272.40M
Net Income 7.21M (52.73M) (13.09M) (12.30M) (1.48M) (75.08M) 31.06M (6.11M)
EPS 0.05 -0.34 -0.09 -0.08 -0.01 -0.60 0.21 -0.05
Free Cash Flow 47.59M 77.71M 6.10M 3.43M 46.92M 26.74M 54.94M 47.13M
FCF / Share 0.33 0.50 0.04 0.02 0.32 0.20 0.38 0.38
Operating CF 165.54M 164.82M 74.33M 63.85M 90.29M 59.54M 92.50M 80.45M
Total Assets 1.27B 1.17B 759.93M 719.19M 670.21M 558.78M 264.62M 215.07M
Total Debt 359.62M 351.89M 66.97M 73.52M 28.61M 1.11M 51.49M 54.88M
Cash & Equiv 314.01M 296.05M 68.17M 91.80M 73.33M 303.05M 75.90M 55.84M
Book Value 258.92M 179.35M 252.98M 229.72M 230.08M 229.34M (112.43M) (111.70M)
Return on Equity 0.03 -0.29 -0.05 -0.05 -0.01 -0.33 N/A N/A
VERX News
Vertex to Participate in Upcoming September Investor Conferences
Aug 26, 2026 12:00 PM · businesswire.com
Vertex Pharmaceuticals Up 15% in a Month: How to Play the Stock
Aug 26, 2026 06:36 AM · zacks.com
Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?
Aug 21, 2026 03:00 PM · fool.com
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Aug 20, 2026 11:30 AM · fool.com
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
Aug 14, 2026 12:00 PM · fool.com
Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)
Aug 14, 2026 05:40 AM · seekingalpha.com
Vertex Report: Rising Sales Tax Rates Signal a New Era of Tax Volatility
Aug 13, 2026 04:00 AM · globenewswire.com
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?
Aug 07, 2026 10:00 AM · fool.com
3 Reasons Why Growth Investors Shouldn't Overlook Vertex (VERX)
Aug 05, 2026 09:46 AM · zacks.com
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday
Aug 04, 2026 01:37 PM · fool.com